Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2–3, non-randomised study
Titel:
Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2–3, non-randomised study
Auteur:
Matovu, Enock Nyirenda, Westain Eriatu, Anthony Alves, Deolinda Perdrieu, Christelle Lemerani, Marshal Wamboga, Charles Lejon, Veerle Seixas, Jorge Signorell, Aita Reymondier, Anne Baudin, Elisabeth Scherrer, Bruno Valverde Mordt, Olaf
Verschenen in:
The Lancet global health
Paginering:
Jaargang 13 () nr. 5 pagina's e910-e919
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license